Clinical Studies with Targeted Toxins in Malignant Glioma

E-ISSN： 1876-1038|1|2|119-131

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.1, Iss.2, 2006-05, pp. : 119-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials with Intracerebral Convection-Enhanced Delivery of Targeted Toxins in Malignant Glioma

Reviews on Recent Clinical Trials, Vol. 3, Iss. 1, 2008-01 ,pp. : 2-9

Bentham Science Publishers

Access to resources Recommend Favorite

Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience

By Sabel Michael Giese Alf

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3239-3257

Informa Healthcare

Access to resources Recommend Favorite

The Safety of the Temozolomide in Patients with Malignant Glioma

Current Drug Safety, Vol. 1, Iss. 2, 2006-05 ,pp. : 205-222

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Malignant Glioma – Quo Vadis?

Oncology Research and Treatment, Vol. 31, Iss. 6, 2008-05 ,pp. : 300-302

Karger

Access to resources Recommend Favorite

Localized BCNU chemotherapy and the multimodal management of malignant glioma

By La Rocca Renato V. Mehdorn H. Maximilian

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 149-160

Informa Healthcare

Access to resources Recommend Favorite